Fingerprint
Dive into the research topics of 'Rituximab provides durable remission in a patient with refractory aggressive diffuse B-cell lymphoma failing salvage chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eric Robach, Celaletin Ustun, Andre Kallab, Russel E. Burgess, Anand P. Jillella
Research output: Contribution to journal › Article › peer-review